Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Headache; Clammy; Bloating; Feeling hot; Nausea; Heart racing; Tiredness; Dizziness/Felt faint; Maternal exposure during pregnancy/Patient was exposed to the medicine second-trimester (13-28 weeks); This is a spontaneous report from a contactable consumer received from a regulatory authority. The regulatory authority report number is GB-MHRA-APPCOVID-202106060922142550-AIHYG. A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown), via an unspecified route of administration on 04Jun2021 (at the age of 32-year-old) as DOSE 1, SINGLE for COVID-19 immunization. Medical history included suspected COVID-19 from 21Mar2020 to 10Apr2020 and was not ongoing. Not had a COVID-19 test. Patient is not enrolled in clinical trial. Patient is not currently breastfeeding. Concomitant medication included aspirin [acetylsalicylic acid] taken for pregnancy from 01Mar2021; folic acid taken for vitamin supplementation. On 04Jun2021, the patient experienced maternal exposure during pregnancy/patient was exposed to the medicine second-trimester (13-28 weeks), dizziness/felt faint, and tiredness. On 05Jun2021, the patient experienced nausea, heart racing, headache, clammy, bloating, and feeling hot. The events were medically significant. Patient has not tested positive for COVID-19 since having the vaccine. Outcome of the headache was recovered on 05Jun2021, of the dizziness/felt faint and feeling hot was recovered on 06Jun2021, of the nausea, heart racing, tiredness, and clammy was recovering, and of the bloating was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166